Pfizer (PFE) Cost of Revenue (2009 - 2026)
Pfizer (PFE) recorded Cost of Revenue of $4.03 billion in Q3 2026, down 3.5% from $4.17 billion a year earlier and down 1.6% from the prior quarter.
Pfizer (PFE) Cost of Revenue (2009 - 2026) Analysis & Trends
On a TTM basis, Pfizer's Cost of Revenue came in at $16.94 billion as of Sep 27, 2026, up 1.4% year-over-year; for FY2025, it came in at $16.07 billion, down 10.0% from FY2024.
- Annual Cost of Revenue has declined for three straight years, though with a five-year compound annual growth rate of 13.6% (FY2020 to FY2025).
- Across earlier years, Cost of Revenue came in at $17.85 billion in FY2024 (-28.5%), $24.95 billion in FY2023 (-27.3%), $34.34 billion in FY2022 (+11.4%) and $30.82 billion in FY2021 (+263.3%).
- Quarterly Cost of Revenue has ranged from $2.85 billion in Q1 2025 to $9.98 billion in Q1 2022 over the past five years.
- On a year-over-year basis, Cost of Revenue rose in three of the last eight quarters, with an average decline of 3.1%.
- Peak year-over-year performance for Cost of Revenue in the last five years was growth of 259.1% in Q4 2021, against a decline of 62.6% in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $4.09 billion (Q2 2026), $3.55 billion (Q1 2026) and $5.27 billion (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 3.93 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 8.10 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 4.29 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 4.89 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 2.95 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 2.79 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 1.57 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 4.03 Bn |
| 10 | Vertex Pharmaceuticals | 136.55 Bn | 104.28 Bn | 2.91 Bn | 526.10 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 27, 2026 | 4.03 Bn |
| Jun 28, 2026 | 4.09 Bn |
| Mar 29, 2026 | 3.55 Bn |
| Dec 31, 2025 | 5.27 Bn |
| Sep 28, 2025 | 4.17 Bn |
| Jun 29, 2025 | 3.78 Bn |
| Mar 30, 2025 | 2.85 Bn |
| Dec 31, 2024 | 5.91 Bn |
| Sep 29, 2024 | 5.26 Bn |
| Jun 30, 2024 | 3.30 Bn |
| Mar 31, 2024 | 3.38 Bn |
| Dec 31, 2023 | 7.56 Bn |
| Oct 1, 2023 | 9.27 Bn |
| Jul 2, 2023 | 3.24 Bn |
| Apr 2, 2023 | 4.89 Bn |
| Dec 31, 2022 | 9.65 Bn |
| Oct 2, 2022 | 6.06 Bn |
| Jul 3, 2022 | 8.65 Bn |
| Apr 3, 2022 | 9.98 Bn |
| Dec 31, 2021 | 9.74 Bn |
Pfizer Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=PFE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "PFE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=PFE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();